Health Catalyst, Inc. (Nasdaq: HCAT), a company that provides technology and services for analyzing healthcare data, has successfully acquired Carevive Systems, a company that focuses on improving the experiences of cancer patients through health technology.
Carevive’s main platform and data are used by healthcare providers and researchers in oncology for various purposes like planning treatments, screening for clinical trials, coordinating care, monitoring patients remotely, and providing post-treatment care. With this acquisition, Health Catalyst aims to enhance its support for improving care and processes in oncology. It also expects to gain better insights into patient-reported outcomes and oncology registry data.
Key Points:
- Acquisition Impact: Health Catalyst has acquired Carevive Systems, a leading company in oncology-focused health technology, to strengthen its capabilities in supporting cancer care and process improvement.
- Utilization of Carevive’s Platform: Carevive’s flagship platform and data are used by oncology providers and researchers for various purposes including treatment planning, clinical trial screening, care coordination, remote patient monitoring, and post-treatment care.
- Enhanced Insights: The acquisition will provide Health Catalyst with improved insights into patient-reported outcomes and oncology registry data, enabling better decision-making in cancer care.
- Shared Mission: Both companies share a commitment to leveraging technology, data, and analytics to advance healthcare. They aim to amplify the patient’s voice in cancer care and contribute to groundbreaking research in oncology.
- Future Collaboration: The partnership between Health Catalyst and Carevive is expected to lead to more innovative solutions for cancer centers and provide researchers with valuable real-world data. Together, they envision a future where patient-centered care and cutting-edge research merge seamlessly.
In simpler terms, Health Catalyst, a company that helps healthcare organizations analyze data, has bought Carevive, a company that focuses on improving the experiences of cancer patients using technology. Carevive’s tools are used by doctors and researchers to plan treatments, find suitable clinical trials, monitor patients, and provide care after treatment. By joining forces, Health Catalyst aims to better support cancer care and gain deeper insights into how patients are doing. Both companies are excited about this partnership and believe it will lead to better care for cancer patients and contribute to important research in the field.
About Health Catalyst
Health Catalyst is a company that specializes in providing data and analytics technology, along with services to healthcare organizations. Here’s a detailed summary of the company:
- Founding Principles: Established by experienced healthcare professionals, Health Catalyst was created with the belief that the knowledge gained from their collective experience should be accessible to all healthcare systems.
- Core Values: The company’s culture is deeply rooted in its unwavering beliefs and values, emphasizing the importance of team member engagement and adherence to operating principles and cultural attributes.
- Mission and Vision: Health Catalyst’s mission is to be a driving force for substantial, measurable, and data-driven healthcare improvement. Their vision is to empower providers with the necessary software, data, and services to optimize patient health outcomes.
- Commitment to Improvement: As a leading provider in its field, Health Catalyst is dedicated to catalyzing significant and quantifiable improvements in healthcare through data-informed decisions.
About Carevive Systems
- Mission and Platform: Carevive Systems is dedicated to transforming cancer care by enhancing the quality of life for cancer patients. It offers a digital platform rooted in real-world patient experiences, aiming to improve patient outcomes and assist cancer programs in adapting to new reimbursement models.
- Core Values: The organization is driven by four key values: passion, innovation, collaboration, and knowledge. These principles guide its commitment to revolutionizing cancer care.
- Founding and Impact: Recognizing the need for better post-treatment care for cancer survivors, co-founders Maddy Herzfeld and Carrie Tompkins Stricker established the company. They developed an evidence-based, personalized care plan to support patients transitioning from active treatment to survivorship.
- Patient-Centric Tools: The company has developed tools for treatment planning and proactive symptom management. These include geriatric assessments and shared decision-making features, allowing patients to actively participate in their care. Additionally, the company’s electronic patient-reported outcomes (ePROs) tools enable real-time symptom reporting, reducing emergency visits and hospitalizations.
Summary
